dc.creatorMorgado, Mariza Gonçalves
dc.creatorGuimarães, Monick Lindenmeyer
dc.creatorCastro Filho, Bernardo Galvão
dc.date2013-01-24T20:55:04Z
dc.date2013-01-24T20:55:04Z
dc.date2002
dc.date.accessioned2023-09-26T22:51:27Z
dc.date.available2023-09-26T22:51:27Z
dc.identifierMORGADO, M.G. et al. HIV-1 polymorphism: a challenge for vaccine development - a review. Memórias do Instituto Oswaldo Cruz, v. 97, n. 2, p. 143-150, mar. 2002.
dc.identifier0074-0276
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/6254
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8884021
dc.descriptionThe perspective for the development of anti-HIV/AIDS vaccines became a target sought by several research groups and pharmaceutical companies. However, the complex virus biology in addition to a striking genetic variability and the limited understanding of the immunological correlates of protection have made this an enormous scientific challenge not overcome so far. In this review we presented an updating of HIV-1 subtypes and recombinant viruses circulating in South American countries, focusing mainly on Brazil, as one of the challenges for HIV vaccine development. Moreover, we discussed the importance of stimulating developing countries to participate in the process of vaccine evaluation, not only testing vaccines according to already defined protocols, but also working together with them, in order to take into consideration their local information on virus diversity and host genetic background relevant for the vaccine development and testing, as well as including local virus based reagents to evaluate the immunogenicity of the candidate vaccines.
dc.formatapplication/pdf
dc.languageeng
dc.rightsopen access
dc.subjectHIV-1 polymorphism
dc.subjectHIV/AIDS
dc.subjectVaccine
dc.subjectVacinas contra AIDS/genética
dc.subjectHIV-1/genética
dc.subjectHIV-1/imunologia
dc.subjectPolimorfismo Genético
dc.subjectVariação Genética
dc.subjectDesenho de Drogas
dc.subjectHumanos
dc.subjectRevisão
dc.titleHIV-1 polymorphism: a challenge for vaccine development - a review
dc.typeArticle


Este ítem pertenece a la siguiente institución